Abemaciclib in meningiomas with somatic or CDK pathway alterations: the phase 2 Alliance A071401 trial

Journal:
Nature Medicine
Published:
Affiliations:
22
Authors:
32
Institutions Authors Share
Massachusetts General Hospital Cancer Center, United States of America (USA)
8.000000
0.25
Mayo Clinic, United States of America (USA)
5.000000
0.16
Holden Comprehensive Cancer Center, UI, United States of America (USA)
1.000000
0.03
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)
1.000000
0.03
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
1.000000
0.03
UPMC Hillman Cancer Center (UPCI), United States of America (USA)
1.000000
0.03
Dartmouth-Hitchcock Medical Center (DHMC), United States of America (USA)
1.000000
0.03
The University of Chicago (UChicago), United States of America (USA)
1.000000
0.03
The University of Texas MD Anderson Cancer Center, United States of America (USA)
1.000000
0.03
Wake Forest University (WFU), United States of America (USA)
1.000000
0.03
Inova Schar Cancer Institute, United States of America (USA)
1.000000
0.03
Mayo Clinic's Campus in Florida, United States of America (USA)
1.000000
0.03
Michigan Medicine, U-M, United States of America (USA)
1.000000
0.03
Weill Cornell Medicine, United States of America (USA)
1.000000
0.03
Rush University Medical Center, United States of America (USA)
1.000000
0.03
Yale Smilow Cancer Hospital, United States of America (USA)
1.000000
0.03
University of Mississippi Medical Center (UMMC), Ole Miss, United States of America (USA)
1.000000
0.03
UNM Comprehensive Cancer Center, United States of America (USA)
1.000000
0.03
Medical Center, UVM, United States of America (USA)
1.000000
0.03
UC San Diego Health Sciences, United States of America (USA)
1.000000
0.03
Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), United States of America (USA)
1.000000
0.03